July 2025
1. SHIN KH, Lee SY, Ju MH, Lee HJ, et al
   Pre-transplant sensitization and its effect on heart transplant rejection and survival outcomes.
   Transpl Immunol. 2025 Jul 22:102264. doi: 10.1016/j.trim.2025.102264.
   

   >> Share

   
   May 2025
2. GABELEH F, Mahdavi M, Niya MHK, Amiri M, et al
   Survey of prevalence of BKV and JCV infections in pediatric heart transplant recipients.
   Transpl Immunol. 2025 May 19:102243. doi: 10.1016/j.trim.2025.102243.
   

   >> Share

   
   March 2025
3. MALAUSSENA Z, Lippincott M, Dimou F
   Mycobacterium haemophilum diagnosed via Karius test in a heart transplant recipient: A case report.
   Transpl Immunol. 2025;90:102221.
   

   >> Share

   
   February 2025
4. KATTIH Z, Iacono A, Saikus C, Esposito M, et al
   Tacrolimus-induced thrombotic microangiopathy (TMA) after heart and lung transplantation successfully treated with eculizumab.
   Transpl Immunol. 2025;88:102169.
   

   >> Share

   
   January 2025
5. SKORIC B, Mjehovic P, Dosen MD, Nekic A, et al
   Lower basophil count after anti-thymocyte globulin induction is associated with lower incidence of acute cellular rejection in heart transplant recipients.
   Transpl Immunol. 2025 Jan 5:102173. doi: 10.1016/j.trim.2025.102173.
   

   >> Share

   
   December 2024
6. GULLO CE, Dos Santos DD, Correa MP, Gil CD, et al
   Expression patterns of Galectin-3 and NLRP3 in Chagas reactivation and graft damage in heart transplants.
   Transpl Immunol. 2024 Dec 5:102159. doi: 10.1016/j.trim.2024.102159.
   

   >> Share

   
   
7. BANSAL S, Itabashi Y, Guerrero-Alba A, Fleming T, et al
   Regulation of cardiac allograft immune responses by microRNA-155.
   Transpl Immunol. 2024;87:102113.
   

   >> Share

   
   October 2024
8. AZIZGOLSHANI N, Blitzer D, Colvin M, Copeland H, et al
   The status of diversity in the heart transplant workforce.
   Transpl Immunol. 2024 Oct 2:102097. doi: 10.1016/j.trim.2024.102097.
   

   >> Share

   
   March 2024
9. WANG Y, Peng X
   Bioinformatics analysis characterizes immune infiltration landscape and identifies potential blood biomarkers for heart transplantation.
   Transpl Immunol. 2024 Mar 16:102036. doi: 10.1016/j.trim.2024.102036.
   

   >> Share

   
   
10. WANG H, Mao X, Zhong Y, Zhao X, et al
    Human amniotic mesenchymal stem cells inhibit immune rejection injury from allogeneic mouse heart transplantation: A preliminary study on the microRNA expression.
    Transpl Immunol. 2024 Mar 5:102022. doi: 10.1016/j.trim.2024.102022.
    

    >> Share

    
    February 2024
11. ALAM A, van Zyl JS, Patel R, Jamil AK, et al
    Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantation.
    Transpl Immunol. 2024 Feb 5:102009. doi: 10.1016/j.trim.2024.102009.
    

    >> Share

    
    September 2023
12. KUCZAJ A, Warwas S, Zakliczynski M, Pawlak S, et al
    Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report.
    Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937.
    

    >> Share

    
    August 2023
13. ALAM A, Van Zyl J, Mckean S, Abdelrehim A, et al
    Rejection! Or is it? Correlation among molecular microscope diagnostic system, histopathology and clinical judgement following heart transplantation.
    Transpl Immunol. 2023 Aug 28:101924. doi: 10.1016/j.trim.2023.101924.
    

    >> Share

    
    
14. TESZAK T, Assabiny A, Kiraly A, Tarjanyi Z, et al
    Extracorporeal photopheresis in the treatment of cardiac allograft rejection: A single-centre experience.
    Transpl Immunol. 2023;79:101853.
    

    >> Share

    
    
15. CREMEN S, Santiago RM, Robinson MW, Gallagher TK, et al
    Biomarkers of biological aging in recipients of solid organ transplantation and clinical outcomes: A scoping review.
    Transpl Immunol. 2023;79:101851.
    

    >> Share

    
    March 2023
16. CHOU-WU E, Kemna M, Ross S, Youngs D, et al
    Association of MICA and AT1R antibodies with antibody mediated rejection and cardiac allograft vasculopathy in a pediatric heart transplant recipient.
    Transpl Immunol. 2023 Mar 6:101811. doi: 10.1016/j.trim.2023.101811.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share